Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
Nita Radhakrishnan, Additional Professor and HOD, Department of Pediatric Hematology-Oncology, shared on LinkedIn:
”Recent publication from our center adds real-world data on the clinical spectrum and outcomes of congenital afibrinogenemia, highlighting severe bleeding risks, diagnostic delays, and ongoing health-system challenges— in resource-limited settings.
Strengthens the case for improved recognition, registries, and access to fibrinogen replacement therapy.”
Read the full article here.
Article: Clinical outcomes and health-system challenges in congenital afibrinogenemia: a single-centre prospective case series
Authors: Nita Radhakrishnan, Savitri Singh, Archit Pandharipande, Eby P. Baby, Hari Gaire
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 29, 2026, 15:50Sweta Agrawal: Expanding Care for PNH Patients in Nepal
-
Jun 29, 2026, 15:17Heghine Khachatryan: Hemostasis at the Crossroads of Thrombosis and Bleeding
-
Jun 29, 2026, 15:07Tomaz Crochemore: From Bleeding to Thrombosis – The Era of Precision Hemostatic Medicine Has Arrived
-
Jun 29, 2026, 14:51Pete Stibbs: Building a Successful Venous Thrombectomy Practice
-
Jun 29, 2026, 14:30Bruno Pougault: Pregnancy and Thrombosis – Balancing Evolutionary Protection Against Clinical Risk
-
Jun 29, 2026, 13:32Omid Seidizadeh: The Full VWD Session from EHA 2026 Is Now Available to Watch
-
Jun 29, 2026, 13:22Cheryl Carcel: Make The Stroke Research More Inclusive for Women, Take The Survey
-
Jun 29, 2026, 13:18Bianca Rocca: New Expert Opinion On the Evolving Debate on Factor XI as a Therapeutic Target
-
Jun 29, 2026, 13:06Francisco Chacón-Lozsán: Intermittent Hemodialysis in the ICU Should not be Monitored Only by ‘Session Completed’